Low back pain is the number one cause of disability in the world. We speak with Professor Manuela Ferreira, Dr. Jaimie Steinmetz, and Dr. Garland Culbreth, who recently published a study exploring the contributing risk factors and impacts of low back pain.
An IHME study based on the 2021 Global Burden of Disease (GBD) study found that in 2020, 619 million people suffered from lower back pain globally.
A new Global Burden of Disease (GBD) 2021 study estimates that by 2050, there will be a 36.4% increase in cases of low back pain from 2020, with the highest increases in Asia and Africa.
Low back pain remains the leading cause of disability globally, and in 2020, there were more than half a billion prevalent cases of low back pain worldwide.
Americans in 2016 spent an estimated $380 billion on low back and neck pain, as well as on joint and limb pain, and other musculoskeletal disorders.
Just 20 conditions make up more than half of all spending on health care in the United States, according to a new comprehensive financial analysis that examines spending by diseases and injuries.
One year after we published our first COVID-19 model, we take a look back at progress made, lessons learned, and how the world has changed.
People across the US are living longer but spending more time in ill health as rates of nonfatal diseases and injuries – including low back pain, major depressive disorder, and diabetes – decline more slowly than death rates, according to a new analysis of 301 acute and chronic diseases and injuries in 188 countries.
People across the world are living longer but spending more time in ill health as rates of nonfatal diseases and injuries – including diabetes and hearing loss – decline more slowly than death rates, according to a new analysis of 301 diseases and injuries in 188 countries.
US health care spending has continued to increase, and now accounts for more than 17% of the US economy. Despite the size and growth of this spending, little is known about how spending on each condition varies by age and across time.
Find answers to frequently asked questions about our COVID-19 projections model.
As many as one in three people worldwide (2.41 billion people) could benefit from rehabilitation (such as physical and occupational therapy or speech and language therapy) at some point in their illness or injury, according to estimates published today in The Lancet in the first global study of its kind.
IHME director and lead modeler Dr. Christopher J.L. Murray shares insights from our latest COVID-19 model run.
British people spend more time with chronic illness and disability than most Europeans. Young adults are hit hard by alcohol and drug use.
Fewer people dying but more live with disability. Mental health disorders, pain, and injuries hindering people’s health. Obesity and high blood sugar replacing lack of food as leading risks.
Rates of premature mortality are two times higher in the most deprived areas of England (Blackpool), compared to the most affluent (Wokingham), according to a new comprehensive analysis of health at a local, national, and regional level across the UK.
Though the rate of HIV/AIDS-related deaths in Namibia has decreased since its peak in 2005, in 2013 it remained the leading cause of death for all ages. In addition, while life expectancy in Namibia declined between 1990 and 2004 – largely due to the HIV/AIDS epidemic – it has rebounded. However, 2013 life expectancy for both sexes is slightly below 1990 levels. These findings come from a new report of Namibia health indicators.
People around the world are living longer, even in some of the poorest countries, but a complex mix of fatal and nonfatal ailments cause a tremendous amount of health loss, according to a new analysis of all major diseases and injuries in 188 countries.
The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories from 1990 to 2017. Previous GBD studies have shown how the decline of mortality rates from 1990 to 2016 has led to an increase in life expectancy, an aging global population, and an expansion of the non-fatal burden of disease and injury. These studies have also shown how a substantial portion of the world’s population experiences non-fatal health loss with considerable heterogeneity among different causes, locations, ages, and sexes. Ongoing objectives of the GBD study include increasing the level of estimation detail, improving analytical strategies, and increasing the amount of high-quality data.
